6533b831fe1ef96bd1299acb
RESEARCH PRODUCT
A Trial of Lopinavir–Ritonavir in Covid-19
Bruno CacopardoAlberto Carmona-bayonasCorrao SalvatorePiero Dalerbasubject
Adult2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralLopinavir/ritonavirPharmacologyLopinavirBetacoronavirusmedicineHumansPandemicsRitonavirBetacoronaviruPandemicCoronavirus InfectionSARS-CoV-2business.industryCOVID-19LopinavirGeneral MedicineCOVID-19 Drug TreatmentRitonavirCoronavirus InfectionsbusinessCoronavirus InfectionsHumanmedicine.drugyear | journal | country | edition | language |
---|---|---|---|---|
2020-01-01 | New England Journal of Medicine |